Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Yukiyoshi Fujita"'
Autor:
Hisao Imai, Yukiyoshi Fujita, Eriko Hiruta, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Teruhiko Kamiya, Mitsuru Sandoh, Satoshi Takei, Kazuya Arai, Hiromi Nishiba, Junnosuke Mogi, Kyoichi Kaira, Koichi Minato
Publikováno v:
Thoracic Cancer, Vol 13, Iss 16, Pp 2301-2308 (2022)
Abstract Background We conducted a multicenter, retrospective study on the efficacy and safety of naldemedine in thoracic cancer patients using opioids in clinical practice. Methods We retrospectively evaluated thoracic cancer patients treated with n
Externí odkaz:
https://doaj.org/article/421afbce18df4ab5a0851a7fff3ca595
Autor:
Yoshiko Kitazume, Hitoshi Kawazoe, Ryuji Uozumi, Tomoe Yoshizawa, Hirotoshi Iihara, Hironori Fujii, Masaya Takahashi, Takahiro Arai, Yasushi Murachi, Yumiko Sato, Takahiro Mikami, Koji Hashiguchi, Tomoko Yamazaki, Katsuyuki Takahashi, Yukiyoshi Fujita, Yuki Hosokawa, Issei Morozumi, Masami Tsuchiya, Atsushi Yokoyama, Hironobu Hashimoto, Masakazu Yamaguchi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract The association between capecitabine efficacy and proton pump inhibitors (PPIs) is controversial. Here, we determined whether co-administration of PPIs affects the real-world effectiveness of capecitabine. This retrospective observational st
Externí odkaz:
https://doaj.org/article/96f14db77f724404b2128c9eb38030de
Autor:
Senri Yamamoto, Hirotoshi Iihara, Ryuji Uozumi, Hitoshi Kawazoe, Kazuki Tanaka, Yukiyoshi Fujita, Masakazu Abe, Hisao Imai, Masato Karayama, Yoh Hayasaki, Chiemi Hirose, Takafumi Suda, Kazuto Nakamura, Akio Suzuki, Yasushi Ohno, Ken-ichirou Morishige, Naoki Inui
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Olanzapine has been reported to be an effective antiemetic in patients receiving carboplatin-based chemotherapy. However, the efficacy of a neurokinin-1 receptor antagonist (NK1RA) added to olanzapine, a 5-hydroxytryptamine-3 rece
Externí odkaz:
https://doaj.org/article/e7f5889a63c04984bd8ab30ae9c8bc6c
Autor:
Senri Yamamoto, Hirotoshi Iihara, Ryuji Uozumi, Hitoshi Kawazoe, Kazuki Tanaka, Yukiyoshi Fujita, Masakazu Abe, Hisao Imai, Masato Karayama, Yoh Hayasaki, Chiemi Hirose, Takafumi Suda, Kazuto Nakamura, Akio Suzuki, Yasushi Ohno, Ken-ichirou Morishige, Naoki Inui
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background The efficacy of olanzapine as an antiemetic agent in cancer chemotherapy has been demonstrated. However, few high-quality reports are available on the evaluation of olanzapine’s efficacy and safety at a low dose of 5 mg among pa
Externí odkaz:
https://doaj.org/article/79cd99ffcbf44d7699d8a53b2348bb06
Autor:
Teruhiko Kamiya, Hisao Imai, Yukiyoshi Fujita, Eriko Hiruta, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Mitsuru Sandoh, Satoshi Takei, Kazuya Arai, Hiromi Nishiba, Junnosuke Mogi, Shiro Koizuka, Taeko Saito, Kyoko Obayashi, Kyoichi Kaira, Koichi Minato
Publikováno v:
Medicina, Vol 59, Iss 3, p 492 (2023)
Background and Objectives: Opioid analgesics, which are used for cancer-related pain management, cause opioid-induced constipation (OIC). Naldemedine, a peripheral opioid receptor antagonist, is an OIC-modifying agent, but no focused efficacy and saf
Externí odkaz:
https://doaj.org/article/ffaa96cbed244667b17832d5412fcaa6
Autor:
Hiromi Nishiba, Hisao Imai, Yukiyoshi Fujita, Eriko Hiruta, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Teruhiko Kamiya, Masako Ito, Satoshi Takei, Masato Matsuura, Junnosuke Mogi, Koichi Minato, Kyoko Obayashi
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 9, p 2672 (2022)
The efficacy and safety of naldemedine for opioid-induced constipation in patients with cancer has not been investigated in clinical practice. We conducted a multicenter, retrospective study to assess the effects of naldemedine among 10 Japanese inst
Externí odkaz:
https://doaj.org/article/706673284280471b86f783ab1967598d
Autor:
Xieyi Zhang, Wangyang Liu, Kazue Edaki, Yuta Nakazawa, Hiroki Kamioka, Atsushi Fujita, Ryoichi Onozato, Misa Iijima, Shigeru Tsuchida, Takahiro Arai, Yukiyoshi Fujita, Kenta Mizoi, Takuo Ogihara
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 2021 (2021)
Multidrug resistance (MDR) due to enhanced drug efflux activity of tumor cells can severely impact the efficacy of antitumor therapies. We recently showed that increased activity of the efflux transporter P-glycoprotein (P-gp) associated with activat
Externí odkaz:
https://doaj.org/article/69d15ea92e944128a255dbaa3e7dfa6b
Autor:
Eriko Hiruta, Yukiyoshi Fujita, Hisao Imai, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Teruhiko Kamiya, Masako Ito, Satoshi Takei, Masato Matsuura, Hiromi Nishiba, Junnosuke Mogi, Mie Kotake, Shiro Koizuka, Koichi Minato
Publikováno v:
Medicina, Vol 57, Iss 11, p 1233 (2021)
Background and Objectives: Naldemedine is a peripherally acting μ-opioid receptor antagonist that improves opioid-induced constipation. Although clinical trials have excluded patients with poor performance status (PS) and those started on naldemedin
Externí odkaz:
https://doaj.org/article/9baf8d2664d2432e9483df6b1bc9fe63
Autor:
Takahiro Arai, Yukiyoshi Fujita, Hisao Imai, Hiroe Matsumoto, Miho Yamazaki, Eriko Hiruta, Yuka Suzuki, Hitoshi Ojima, Hisashi Hosaka, Koichi Minato, Taeko Saito
Publikováno v:
Medicina, Vol 57, Iss 8, p 801 (2021)
Background and Objectives: Seasonal climatic changes may affect the development of the rash that is characteristic of treatment with anti-epidermal growth factor receptor (EGFR) antibodies. We evaluated the association between seasons and rash incide
Externí odkaz:
https://doaj.org/article/2a1735a2915444eb96ef84bc8e60eb14
Publikováno v:
Journal of Pharmacological Sciences, Vol 91, Iss 4, Pp 319-329 (2003)
Effects of DX-9065a ((+)-2S-2-[4-[[(3S)-1-acetimidoyl-3-pyrrolidinyl]oxy]phenyl]-3-[7-amidino-2-naphthyl]propanoic acid hydrochloride pentahydrate), a dibasic propanoic acid and an inhibitor of factor Xa, were compared with those of argatroban, a low
Externí odkaz:
https://doaj.org/article/f826b427aabf437e88f241f504ef88a0